Travere Therapeutics, Inc. financial data

Symbol
TVTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
3611 Valley Centre Dr, Suite 300, San Diego, CA
State of incorporation
CA
Fiscal year end
December 31
Former names
Retrophin, Inc. (to 11/13/2020), Desert Gateway, Inc. (to 2/19/2013)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 270 % -36.1%
Quick Ratio 25.5 % +175%
Debt-to-equity 866 % +125%
Return On Equity -542 % -877%
Return On Assets -56.1 % -391%
Operating Margin -176 % +40.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78M shares +3.87%
Common Stock, Shares, Outstanding 77.9M shares +3.72%
Entity Public Float 1.15B USD -25.6%
Common Stock, Value, Issued 8K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 77.8M shares +1.93%
Weighted Average Number of Shares Outstanding, Diluted 77.8M shares +1.93%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 203M USD +57.1%
Research and Development Expense 7.5M USD
Costs and Expenses 561M USD +9.93%
Operating Income (Loss) -357M USD +6.12%
Nonoperating Income (Expense) 8.63M USD +13.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -349M USD +6.55%
Income Tax Expense (Benefit) 260K USD +19.3%
Net Income (Loss) Attributable to Parent -351M USD -304%
Earnings Per Share, Basic -4.55 USD/shares -212%
Earnings Per Share, Diluted -4.55 USD/shares -212%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.4M USD -74.8%
Accounts Receivable, after Allowance for Credit Loss, Current 25.2M USD +72.8%
Inventory, Net 42.9M USD +106%
Assets, Current 325M USD -52.7%
Property, Plant and Equipment, Net 6.16M USD -22.9%
Operating Lease, Right-of-Use Asset 15.7M USD -16.7%
Intangible Assets, Net (Excluding Goodwill) 104M USD -2.52%
Goodwill 800K USD 0%
Other Assets, Noncurrent 17.1M USD +32.6%
Assets 504M USD -39.4%
Accounts Payable, Current 23.2M USD -6.23%
Accrued Liabilities, Current 83.9M USD -12.3%
Contract with Customer, Liability, Current 3.8M USD -57.6%
Liabilities, Current 190M USD +36.3%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 18.6M USD -22.1%
Other Liabilities, Noncurrent 16.3M USD +94.3%
Liabilities 535M USD -3.29%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.02M USD +72.2%
Retained Earnings (Accumulated Deficit) -1.39B USD -33.9%
Stockholders' Equity Attributable to Parent -30.5M USD -111%
Liabilities and Equity 504M USD -39.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -119M USD -46.7%
Net Cash Provided by (Used in) Financing Activities -525K USD -100%
Net Cash Provided by (Used in) Investing Activities 105M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 77.9M shares +3.72%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.9M USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 36.4M USD -74.8%
Deferred Tax Assets, Valuation Allowance 291M USD -0.93%
Deferred Tax Assets, Gross 296M USD -1.26%
Operating Lease, Liability 23.9M USD -16.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -349M USD -283%
Lessee, Operating Lease, Liability, to be Paid 27.1M USD -19.2%
Property, Plant and Equipment, Gross 14.9M USD +4.76%
Operating Lease, Liability, Current 5.3M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.89M USD +3.24%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.67M USD +2.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.18M USD -34.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.06M USD +2.54%
Deferred Tax Assets, Operating Loss Carryforwards 81.5M USD +63.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 22.9M USD +99.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.78M USD -32.3%
Additional Paid in Capital 1.36B USD +2.93%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 39M USD +45.7%
Depreciation, Depletion and Amortization 9.88M USD +49.2%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 35.8M USD -20.1%
Interest Expense 11.2M USD -1.75%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%